{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:17:49Z","timestamp":1783163869811,"version":"3.54.6"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11505-6","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:38:29Z","timestamp":1773315509000},"page":"6095-6113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["2-Quinolone-1,2,3-triazole-benzofuran-N-acylhydrazone hybrids as antiviral and antimicrobial agents: synthesis, in vitro screening and molecular modeling"],"prefix":"10.1007","volume":"30","author":[{"given":"Khadija","family":"El Gadali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriem","family":"Rafya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Az-eddine","family":"El Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Mehdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Andrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatiha","family":"Benkhalti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh S.","family":"Sanghvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moha","family":"Taourirte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan B.","family":"Lazrek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"11505_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/pathogens10020144","volume":"10","author":"W Little","year":"2021","unstructured":"Little W, Black C, Smith AC (2021) Clinical implications of polymicrobial synergism effects on antimicrobial susceptibility. Pathogens 10:144. https:\/\/doi.org\/10.3390\/pathogens10020144","journal-title":"Pathogens"},{"key":"11505_CR2","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.mpmed.2021.09.011","volume":"49","author":"A Jeffery-Smith","year":"2021","unstructured":"Jeffery-Smith A, Riddell A (2021) Herpesviruses Med 49:780\u2013784. https:\/\/doi.org\/10.1016\/j.mpmed.2021.09.011","journal-title":"Herpesviruses Med"},{"key":"11505_CR3","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1080\/21505594.2021.1982373","volume":"12","author":"S Zhu","year":"2021","unstructured":"Zhu S, Viejo-Borbolla A (2021) Pathogenesis and virulence of herpes simplex virus. Virulence 12:2670\u20132702. https:\/\/doi.org\/10.1080\/21505594.2021.1982373","journal-title":"Virulence"},{"key":"11505_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0019-2791(76)90297-4","volume":"13","author":"LM Krausz","year":"1976","unstructured":"Krausz LM, Grossberg AL, Pressman D (1976) The chemical nature of the combining site of rabbit anti-p-azophenylphosphorylcholine antibody. Immunochemistry 13:51\u201357. https:\/\/doi.org\/10.1016\/0019-2791(76)90297-4","journal-title":"Immunochemistry"},{"key":"11505_CR5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3390\/v10110609","volume":"10","author":"PGE Kennedy","year":"2018","unstructured":"Kennedy PGE, Gershon AA (2018) Clinical Features of Varicella-Zoster virus infection. Viruses 10:609. https:\/\/doi.org\/10.3390\/v10110609","journal-title":"Viruses"},{"key":"11505_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.coviro.2021.12.002","volume":"52","author":"X Ye","year":"2022","unstructured":"Ye X, Ku Z, Zhang N et al (2022) Recent progress in development of monoclonal antibodies against human cytomegalovirus. Curr Opin Virol 52:166\u2013173. https:\/\/doi.org\/10.1016\/j.coviro.2021.12.002","journal-title":"Curr Opin Virol"},{"key":"11505_CR7","doi-asserted-by":"publisher","first-page":"e1005701","DOI":"10.1371\/journal.ppat.1005701","volume":"12","author":"FR van Diemen","year":"2016","unstructured":"van Diemen FR, Kruse EM, Hooykaas MJG et al (2016) CRISPR\/Cas9-mediated genome editing of Herpesviruses limits productive and latent infections. PLoS Pathog 12:e1005701. https:\/\/doi.org\/10.1371\/journal.ppat.1005701","journal-title":"PLoS Pathog"},{"key":"11505_CR8","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/microorganisms13040905","volume":"13","author":"F Ricchi","year":"2025","unstructured":"Ricchi F, Caramaschi S, Sala A et al (2025) Candida albicans as a trailblazer for herpes simplex virus-2 infection against an in vitro reconstituted human vaginal epithelium. Microorganisms 13:905. https:\/\/doi.org\/10.3390\/microorganisms13040905","journal-title":"Microorganisms"},{"key":"11505_CR9","doi-asserted-by":"publisher","unstructured":"Schlievert PM, Roller RJ, Kilgore SH, Staphylococcal et al TSST-1 Association with eczema herpeticum in humans. mSphere 6:e00608\u2013e00621. https:\/\/doi.org\/10.1128\/mSphere.00608-21","DOI":"10.1128\/mSphere.00608-21"},{"key":"11505_CR10","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1111\/cmi.12674","volume":"18","author":"S Dhamgaye","year":"2016","unstructured":"Dhamgaye S, Qu Y, Peleg AY (2016) Polymicrobial infections involving clinically relevant Gram-negative bacteria and fungi: bacterial-fungal interactions. Cell Microbiol 18:1716\u20131722. https:\/\/doi.org\/10.1111\/cmi.12674","journal-title":"Cell Microbiol"},{"key":"11505_CR11","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.3390\/antibiotics11121731","volume":"11","author":"VT Anju","year":"2022","unstructured":"Anju VT, Busi S, Imchen M et al (2022) Polymicrobial Infections and Biofilms: Clinical Significance and Eradication Strategies. Antibiotics 11:1731. https:\/\/doi.org\/10.3390\/antibiotics11121731","journal-title":"Antibiotics"},{"key":"11505_CR12","doi-asserted-by":"publisher","first-page":"7593","DOI":"10.3390\/molecules28227593","volume":"28","author":"D Buchanan","year":"2023","unstructured":"Buchanan D, Pham AM, Singh SK, Panda SS (2023) Molecular hybridization of Alkaloids using 1,2,3-Triazole-based click chemistry. Molecules 28:7593. https:\/\/doi.org\/10.3390\/molecules28227593","journal-title":"Molecules"},{"key":"11505_CR13","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.3390\/molecules28083342","volume":"28","author":"DI Leite","year":"2023","unstructured":"Leite DI, de Castro Bazan Moura S, da Concei\u00e7\u00e3o Avelino Dias M et al (2023) A review of the development of multitarget molecules against HIV-TB coinfection pathogens. Molecules 28:3342. https:\/\/doi.org\/10.3390\/molecules28083342","journal-title":"Molecules"},{"key":"11505_CR14","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1016\/j.bmcl.2015.06.027","volume":"25","author":"T Tashima","year":"2015","unstructured":"Tashima T (2015) The structural use of carbostyril in physiologically active substances. Bioorg Med Chem Lett 25:3415\u20133419. https:\/\/doi.org\/10.1016\/j.bmcl.2015.06.027","journal-title":"Bioorg Med Chem Lett"},{"key":"11505_CR15","doi-asserted-by":"publisher","first-page":"5610","DOI":"10.1039\/C9RA09510A","volume":"10","author":"A Rani","year":"2020","unstructured":"Rani A, Singh G, Singh A et al (2020) CuAAC-ensembled 1,2,3-triazole-linked isosteres as pharmacophores in drug discovery: review. RSC Adv 10:5610\u20135635. https:\/\/doi.org\/10.1039\/C9RA09510A","journal-title":"RSC Adv"},{"key":"11505_CR16","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.ejmech.2018.06.028","volume":"155","author":"H Kaoukabi","year":"2018","unstructured":"Kaoukabi H, Kabri Y, Curti C et al (2018) Dihydropyrimidinone\/1,2,3-triazole hybrid molecules: synthesis and anti-varicella-zoster virus (VZV) evaluation. Eur J Med Chem 155:772\u2013781. https:\/\/doi.org\/10.1016\/j.ejmech.2018.06.028","journal-title":"Eur J Med Chem"},{"key":"11505_CR17","doi-asserted-by":"publisher","first-page":"144537","DOI":"10.1016\/j.molstruc.2025.144537","volume":"1352","author":"S Lachhab","year":"2026","unstructured":"Lachhab S, Elmoussaoui S, Rafya M et al (2026) New 1,2,3-triazole-\u03b1-aminophosphonate acyclic nucleosides scaffold: design, synthesis, docking studies and biological evaluation as potential S. aureus agents. J Mol Struct 1352:144537. https:\/\/doi.org\/10.1016\/j.molstruc.2025.144537","journal-title":"J Mol Struct"},{"key":"11505_CR18","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1134\/S1068162024040277","volume":"50","author":"G Venkanna","year":"2024","unstructured":"Venkanna G, Rao AT, Kumar KS et al (2024) Design, synthesis, and antimicrobial evaluation of quinolones containing 1,2,3-triazole moieties: in Silico docking techniques. Russ J Bioorg Chem 50:1519\u20131534. https:\/\/doi.org\/10.1134\/S1068162024040277","journal-title":"Russ J Bioorg Chem"},{"key":"11505_CR19","doi-asserted-by":"publisher","first-page":"135179","DOI":"10.1016\/j.molstruc.2023.135179","volume":"1282","author":"KE Gadali","year":"2023","unstructured":"Gadali KE, Rafya M, Mansouri AE et al (2023) Synthesis, structural characterization and antibacterial activity evaluation of novel quinolone-1,2,3-triazole-benzimidazole hybrids. J Mol Struct 1282:135179. https:\/\/doi.org\/10.1016\/j.molstruc.2023.135179","journal-title":"J Mol Struct"},{"key":"11505_CR20","doi-asserted-by":"publisher","first-page":"116235","DOI":"10.1016\/j.ejmech.2024.116235","volume":"268","author":"KE Gadali","year":"2024","unstructured":"Gadali KE, Rafya M, El Mansouri A et al (2024) Design, synthesis, and molecular modeling studies of novel 2-quinolone-1,2,3-triazole-\u03b1-aminophosphonates hybrids as dual antiviral and antibacterial agents. Eur J Med Chem 268:116235. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116235","journal-title":"Eur J Med Chem"},{"key":"11505_CR21","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1134\/S1070363218070265","volume":"88","author":"V Sunitha","year":"2018","unstructured":"Sunitha V, Kumar AK, Shankaraiah P et al (2018) Synthesis and antibacterial evaluation of benzofuran based Di-1,2,3-triazoles. Russ J Gen Chem 88:1515\u20131524. https:\/\/doi.org\/10.1134\/S1070363218070265","journal-title":"Russ J Gen Chem"},{"key":"11505_CR22","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1517\/13543776.2014.959491","volume":"24","author":"RDC Maia","year":"2014","unstructured":"Maia RDC, Tesch R, Fraga CAM (2014) Acylhydrazone derivatives: a patent review. Expert Opin Ther Pat 24:1161\u20131170. https:\/\/doi.org\/10.1517\/13543776.2014.959491","journal-title":"Expert Opin Ther Pat"},{"key":"11505_CR23","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.3390\/molecules26164908","volume":"26","author":"R Munir","year":"2021","unstructured":"Munir R, Javid N, Zia-ur-Rehman M et al (2021) Synthesis of novel N-acylhydrazones and their C\u2013N\/N\u2013N bond conformational characterization by NMR spectroscopy. Molecules 26:4908. https:\/\/doi.org\/10.3390\/molecules26164908","journal-title":"Molecules"},{"key":"11505_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jddst.2017.09.012","volume":"43","author":"C Shen","year":"2018","unstructured":"Shen C, Shen B, Liu X, Yuan H (2018) Nanosuspensions based gel as delivery system of nitrofurazone for enhanced dermal bioavailability. J Drug Deliv Sci Technol 43:1\u201311. https:\/\/doi.org\/10.1016\/j.jddst.2017.09.012","journal-title":"J Drug Deliv Sci Technol"},{"key":"11505_CR25","doi-asserted-by":"publisher","first-page":"129649","DOI":"10.1016\/j.molstruc.2020.129649","volume":"1230","author":"MB Alshammari","year":"2021","unstructured":"Alshammari MB, Ramadan M, Aly AA et al (2021) Synthesis of potentially new schiff bases of N-substituted-2-quinolonylacetohydrazides as anti-COVID-19 agents. J Mol Struct 1230:129649. https:\/\/doi.org\/10.1016\/j.molstruc.2020.129649","journal-title":"J Mol Struct"},{"key":"11505_CR26","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.15376\/biores.15.1.1085-1097","volume":"15","author":"SK Hosseinihashemi","year":"2019","unstructured":"Hosseinihashemi SK, Toolabi M, Abedinifar F et al (2019) Synthesis and activity evaluation of new benzofuran-1,3,4-oxadiazole hybrids against wood-degrading fungi. BioRes 15:1085\u20131097. https:\/\/doi.org\/10.15376\/biores.15.1.1085-1097","journal-title":"BioRes"},{"key":"11505_CR27","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1128\/AAC.00345-07","volume":"51","author":"J Meletiadis","year":"2007","unstructured":"Meletiadis J, Antachopoulos C, Stergiopoulou T et al (2007) Differential fungicidal activities of amphotericin B and voriconazole against aspergillus species determined by microbroth methodology. Antimicrob Agents Chemother 51:3329\u20133337. https:\/\/doi.org\/10.1128\/AAC.00345-07","journal-title":"Antimicrob Agents Chemother"},{"key":"11505_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-3-642-57092-6_6","volume-title":"Proteases as Targets for Therapy","author":"CE Dabrowski","year":"2000","unstructured":"Dabrowski CE, Qiu X, Abdel-Meguid SS (2000) The Human Herpes-Virus Proteases. In: Von Der Helm K, Korant BD, Cheronis JC (eds) Proteases as Targets for Therapy. Springer, Berlin Heidelberg, Berlin, Heidelberg, pp 95\u2013115"},{"key":"11505_CR29","doi-asserted-by":"publisher","first-page":"105604","DOI":"10.1016\/j.antiviral.2023.105604","volume":"213","author":"M Pachota","year":"2023","unstructured":"Pachota M, Grzywa R, Iwanejko J et al (2023) Novel inhibitors of HSV-1 protease effective in vitro and in vivo. Antiviral Res 213:105604. https:\/\/doi.org\/10.1016\/j.antiviral.2023.105604","journal-title":"Antiviral Res"},{"key":"11505_CR30","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.chembiol.2022.03.007","volume":"29","author":"KR Hulce","year":"2022","unstructured":"Hulce KR, Jaishankar P, Lee GM et al (2022) Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine. Cell Chem Biology 29:785\u2013798e19. https:\/\/doi.org\/10.1016\/j.chembiol.2022.03.007","journal-title":"Cell Chem Biology"},{"key":"11505_CR31","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.3390\/molecules24162912","volume":"24","author":"STS Hassan","year":"2019","unstructured":"Hassan STS, \u0160udomov\u00e1 M, Berchov\u00e1-B\u00edmov\u00e1 K et al (2019) Psoromic acid, a lichen-derived molecule, inhibits the replication of HSV-1 and HSV-2, and inactivates HSV-1 DNA polymerase: shedding light on antiherpetic properties. Molecules 24:2912. https:\/\/doi.org\/10.3390\/molecules24162912","journal-title":"Molecules"},{"key":"11505_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/biomedicines11020371","volume":"11","author":"AC Spencer","year":"2023","unstructured":"Spencer AC, Panda SS (2023) DNA gyrase as a target for quinolones. Biomedicines 11:371. https:\/\/doi.org\/10.3390\/biomedicines11020371","journal-title":"Biomedicines"},{"key":"11505_CR33","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1007\/s00044-021-02798-3","volume":"30","author":"HAA Ezelarab","year":"2021","unstructured":"Ezelarab HAA, Abbas SH, Abourehab MAS et al (2021) Novel antimicrobial ciprofloxacin-pyridinium quaternary ammonium salts with improved physicochemical properties and DNA gyrase inhibitory activity. Med Chem Res 30:2168\u20132183. https:\/\/doi.org\/10.1007\/s00044-021-02798-3","journal-title":"Med Chem Res"},{"key":"11505_CR34","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s13738-022-02704-7","volume":"20","author":"HAA Ezelarab","year":"2023","unstructured":"Ezelarab HAA, Hassan HA, Abuo-Rahma GE-DA, Abbas SH (2023) Design, synthesis, and biological investigation of quinoline\/ciprofloxacin hybrids as antimicrobial and anti-proliferative agents. J Iran CHEM SOC 20:683\u2013700. https:\/\/doi.org\/10.1007\/s13738-022-02704-7","journal-title":"J Iran CHEM SOC"},{"key":"11505_CR35","doi-asserted-by":"publisher","first-page":"107314","DOI":"10.1016\/j.bioorg.2024.107314","volume":"147","author":"W Xue","year":"2024","unstructured":"Xue W, Zuo X, Zhao X et al (2024) Bioisosteric replacement strategy leads to novel DNA gyrase B inhibitors with improved potencies and properties. Bioorg Chem 147:107314. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107314","journal-title":"Bioorg Chem"},{"key":"11505_CR36","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1016\/j.bmc.2014.06.041","volume":"22","author":"J Renuka","year":"2014","unstructured":"Renuka J, Reddy KI, Srihari K et al (2014) Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis. Bioorg Med Chem 22:4924\u20134934. https:\/\/doi.org\/10.1016\/j.bmc.2014.06.041","journal-title":"Bioorg Med Chem"},{"key":"11505_CR37","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3390\/ph17121664","volume":"17","author":"SS Abd El-Karim","year":"2024","unstructured":"Abd El-Karim SS, Anwar MM, Syam YM et al (2024) New benzofuran\u2013pyrazole-based compounds as promising antimicrobial agents: design, synthesis, DNA gyrase B inhibition, and in Silico studies. Pharmaceuticals 17:1664. https:\/\/doi.org\/10.3390\/ph17121664","journal-title":"Pharmaceuticals"},{"key":"11505_CR38","doi-asserted-by":"publisher","unstructured":"DeJarnette C, Luna-Tapia A, Estredge LR, Palmer GE (2020) Dihydrofolate reductase is a valid target for antifungal development in the human pathogen Candida albicans. mSphere 5. https:\/\/doi.org\/10.1128\/msphere.00374-20. 10.1128\/msphere.00374\u2009\u2013\u200920","DOI":"10.1128\/msphere.00374-20"},{"key":"11505_CR39","doi-asserted-by":"publisher","first-page":"19385","DOI":"10.1021\/acs.jafc.3c05216","volume":"71","author":"R Feng","year":"2023","unstructured":"Feng R, Sun B, Zhang S et al (2023) Discovery of novel rhizoctonia solani DHFR inhibitors as fungicides using virtual screening. J Agric Food Chem 71:19385\u201319395. https:\/\/doi.org\/10.1021\/acs.jafc.3c05216","journal-title":"J Agric Food Chem"},{"key":"11505_CR40","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.chembiol.2008.07.013","volume":"15","author":"J Liu","year":"2008","unstructured":"Liu J, Bolstad DB, Smith AE et al (2008) Structure-guided development of efficacious antifungal agents targeting candida glabrata dihydrofolate reductase. Chem Biol 15:990\u2013996. https:\/\/doi.org\/10.1016\/j.chembiol.2008.07.013","journal-title":"Chem Biol"},{"key":"11505_CR41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1515\/hc-2016-0073","volume":"23","author":"SM Somagond","year":"2017","unstructured":"Somagond SM, Kamble RR, Kattimani PP et al (2017) Design, synthesis, docking and in vitro antifungal study of 1,2,4-triazole hybrids of 2-(aryloxy)quinolines. Heterocycl Commun 23:317\u2013324. https:\/\/doi.org\/10.1515\/hc-2016-0073","journal-title":"Heterocycl Commun"},{"key":"11505_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/7834474","volume":"2023","author":"L Emami","year":"2023","unstructured":"Emami L, Jamshidzadeh A, Khabnadideh S et al (2023) n vivo antifungal activity and computational studies of some Azole derivatives against Candida Albicans. J Chem 2023:1\u201312. https:\/\/doi.org\/10.1155\/2023\/7834474","journal-title":"J Chem"},{"key":"11505_CR43","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4155\/fmc-2023-0251","volume":"16","author":"P Periwal","year":"2024","unstructured":"Periwal P, Verma V, Kumar D et al (2024) Novel Azole\u2013Sulfonamide conjugates as potential antimicrobial candidates: synthesis and biological assessment. Future Med Chem 16:157\u2013171. https:\/\/doi.org\/10.4155\/fmc-2023-0251","journal-title":"Future Med Chem"},{"key":"11505_CR44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00894-022-05185-w","volume":"28","author":"S Mujwar","year":"2022","unstructured":"Mujwar S, Tripathi A (2022) Repurposing benzbromarone as antifolate to develop novel antifungal therapy for Candida albicans. J Mol Model 28:193. https:\/\/doi.org\/10.1007\/s00894-022-05185-w","journal-title":"J Mol Model"},{"key":"11505_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/antibiotics13010075","volume":"13","author":"M Coand\u0103","year":"2024","unstructured":"Coand\u0103 M, Limban C, Nu\u021b\u0103 DC (2024) Small schiff base molecules\u2014a possible strategy to combat biofilm-related infections. Antibiotics 13:75. https:\/\/doi.org\/10.3390\/antibiotics13010075","journal-title":"Antibiotics"},{"key":"11505_CR46","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2174\/1573409918666220610162158","volume":"18","author":"R Thorat","year":"2022","unstructured":"Thorat R, Mali BN, Wagh SR, Yamgar RS R (2022) Synthesis, molecular docking, antioxidant, Anti-TB, and potent MCF-7anticancer studies of novel Aryl-carbohydrazide analogues. CAD 18:247\u2013257. https:\/\/doi.org\/10.2174\/1573409918666220610162158","journal-title":"CAD"},{"key":"11505_CR47","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"11505_CR48","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"P Banerjee","year":"2018","unstructured":"Banerjee P, Eckert AO, Schrey AK, Preissner R (2018) ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res 46:W257\u2013W263. https:\/\/doi.org\/10.1093\/nar\/gky318","journal-title":"Nucleic Acids Res"},{"key":"11505_CR49","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technol 1:337\u2013341. https:\/\/doi.org\/10.1016\/j.ddtec.2004.11.007","journal-title":"Drug Discovery Today: Technol"},{"key":"11505_CR50","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3390\/pharmaceutics11080411","volume":"11","author":"D Dahlgren","year":"2019","unstructured":"Dahlgren D, Lennern\u00e4s H (2019) Intestinal permeability and drug absorption: predictive experimental, computational and in vivo approaches. Pharmaceutics 11:411. https:\/\/doi.org\/10.3390\/pharmaceutics11080411","journal-title":"Pharmaceutics"},{"key":"11505_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1590\/S1984-82502012000300002","volume":"48","author":"KMR Srivalli","year":"2012","unstructured":"Srivalli KMR, Lakshmi PK (2012) Overview of P-glycoprotein inhibitors: a rational outlook. Braz J Pharm Sci 48:353\u2013367. https:\/\/doi.org\/10.1590\/S1984-82502012000300002","journal-title":"Braz J Pharm Sci"},{"key":"11505_CR52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ddc4020024","volume":"4","author":"M Kond\u017ea","year":"2025","unstructured":"Kond\u017ea M, Buki\u0107 J, \u0106avar I, Tubi\u0107 B (2025) Targeted but troubling: CYP450 inhibition by kinase and PARP inhibitors and its clinical implications. Drugs Drug Candidates 4:24. https:\/\/doi.org\/10.3390\/ddc4020024","journal-title":"Drugs Drug Candidates"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11505-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11505-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11505-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:38:38Z","timestamp":1783161518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11505-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["11505"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11505-6","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}